nodes	percent_of_prediction	percent_of_DWPC	metapath
Anastrozole—breast cancer—bone cancer	0.679	1	CtDrD
Anastrozole—CYP3A4—bone cancer	0.26	1	CbGaD
Anastrozole—CYP1A2—Lidocaine metabolism—CYP3A4—bone cancer	0.00051	0.0997	CbGpPWpGaD
Anastrozole—CYP19A1—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000443	0.0866	CbGpPWpGaD
Anastrozole—CYP2C9—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000196	0.0383	CbGpPWpGaD
Anastrozole—CYP19A1—Metapathway biotransformation—CYP4V2—bone cancer	0.000191	0.0373	CbGpPWpGaD
Anastrozole—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—bone cancer	0.000187	0.0366	CbGpPWpGaD
Anastrozole—CYP1A2—Aflatoxin B1 metabolism—CYP3A4—bone cancer	0.000187	0.0366	CbGpPWpGaD
Anastrozole—CYP1A2—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000167	0.0327	CbGpPWpGaD
Anastrozole—Cerebrovascular accident—Methotrexate—bone cancer	0.000158	0.00283	CcSEcCtD
Anastrozole—Lethargy—Methotrexate—bone cancer	0.000158	0.00283	CcSEcCtD
Anastrozole—Ill-defined disorder—Cisplatin—bone cancer	0.000157	0.00282	CcSEcCtD
Anastrozole—Anaemia—Cisplatin—bone cancer	0.000157	0.00281	CcSEcCtD
Anastrozole—Hot flush—Epirubicin—bone cancer	0.000154	0.00277	CcSEcCtD
Anastrozole—Thrombophlebitis—Doxorubicin—bone cancer	0.000154	0.00277	CcSEcCtD
Anastrozole—Osteoarthritis—Methotrexate—bone cancer	0.000154	0.00277	CcSEcCtD
Anastrozole—Increased appetite—Epirubicin—bone cancer	0.000154	0.00276	CcSEcCtD
Anastrozole—Blood alkaline phosphatase increased—Doxorubicin—bone cancer	0.000154	0.00276	CcSEcCtD
Anastrozole—Menopausal symptoms—Epirubicin—bone cancer	0.000153	0.00275	CcSEcCtD
Anastrozole—Malaise—Cisplatin—bone cancer	0.000153	0.00274	CcSEcCtD
Anastrozole—Leukopenia—Cisplatin—bone cancer	0.000152	0.00272	CcSEcCtD
Anastrozole—Dermatitis bullous—Epirubicin—bone cancer	0.000151	0.00271	CcSEcCtD
Anastrozole—Anaphylactoid reaction—Epirubicin—bone cancer	0.000149	0.00268	CcSEcCtD
Anastrozole—Cerebrovascular accident—Epirubicin—bone cancer	0.000147	0.00265	CcSEcCtD
Anastrozole—Lethargy—Epirubicin—bone cancer	0.000147	0.00265	CcSEcCtD
Anastrozole—Mood swings—Methotrexate—bone cancer	0.000146	0.00262	CcSEcCtD
Anastrozole—Osteoarthritis—Epirubicin—bone cancer	0.000144	0.00259	CcSEcCtD
Anastrozole—Myalgia—Cisplatin—bone cancer	0.000144	0.00259	CcSEcCtD
Anastrozole—Anxiety—Cisplatin—bone cancer	0.000144	0.00258	CcSEcCtD
Anastrozole—Hot flush—Doxorubicin—bone cancer	0.000143	0.00256	CcSEcCtD
Anastrozole—Liver function test abnormal—Methotrexate—bone cancer	0.000143	0.00256	CcSEcCtD
Anastrozole—Discomfort—Cisplatin—bone cancer	0.000143	0.00256	CcSEcCtD
Anastrozole—Increased appetite—Doxorubicin—bone cancer	0.000142	0.00255	CcSEcCtD
Anastrozole—Menopausal symptoms—Doxorubicin—bone cancer	0.000142	0.00254	CcSEcCtD
Anastrozole—Dermatitis bullous—Doxorubicin—bone cancer	0.00014	0.00251	CcSEcCtD
Anastrozole—Anaphylactic shock—Cisplatin—bone cancer	0.000138	0.00248	CcSEcCtD
Anastrozole—Oedema—Cisplatin—bone cancer	0.000138	0.00248	CcSEcCtD
Anastrozole—Anaphylactoid reaction—Doxorubicin—bone cancer	0.000138	0.00248	CcSEcCtD
Anastrozole—Infection—Cisplatin—bone cancer	0.000137	0.00247	CcSEcCtD
Anastrozole—Mood swings—Epirubicin—bone cancer	0.000137	0.00246	CcSEcCtD
Anastrozole—Lethargy—Doxorubicin—bone cancer	0.000136	0.00245	CcSEcCtD
Anastrozole—Cerebrovascular accident—Doxorubicin—bone cancer	0.000136	0.00245	CcSEcCtD
Anastrozole—Osteoarthritis—Doxorubicin—bone cancer	0.000134	0.0024	CcSEcCtD
Anastrozole—Hyperhidrosis—Cisplatin—bone cancer	0.000134	0.0024	CcSEcCtD
Anastrozole—Liver function test abnormal—Epirubicin—bone cancer	0.000133	0.00239	CcSEcCtD
Anastrozole—Anorexia—Cisplatin—bone cancer	0.000132	0.00237	CcSEcCtD
Anastrozole—Aspartate aminotransferase increased—Epirubicin—bone cancer	0.00013	0.00233	CcSEcCtD
Anastrozole—CYP3A4—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000129	0.0253	CbGpPWpGaD
Anastrozole—Alanine aminotransferase increased—Epirubicin—bone cancer	0.000127	0.00229	CcSEcCtD
Anastrozole—Mood swings—Doxorubicin—bone cancer	0.000127	0.00227	CcSEcCtD
Anastrozole—Musculoskeletal discomfort—Cisplatin—bone cancer	0.000126	0.00226	CcSEcCtD
Anastrozole—Dysphagia—Epirubicin—bone cancer	0.000125	0.00224	CcSEcCtD
Anastrozole—Influenza—Epirubicin—bone cancer	0.000125	0.00224	CcSEcCtD
Anastrozole—Paraesthesia—Cisplatin—bone cancer	0.000124	0.00223	CcSEcCtD
Anastrozole—Liver function test abnormal—Doxorubicin—bone cancer	0.000123	0.00221	CcSEcCtD
Anastrozole—Dyspnoea—Cisplatin—bone cancer	0.000123	0.00221	CcSEcCtD
Anastrozole—Angina pectoris—Epirubicin—bone cancer	0.000122	0.00218	CcSEcCtD
Anastrozole—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.000122	0.0238	CbGpPWpGaD
Anastrozole—Aspartate aminotransferase increased—Doxorubicin—bone cancer	0.00012	0.00216	CcSEcCtD
Anastrozole—Decreased appetite—Cisplatin—bone cancer	0.00012	0.00216	CcSEcCtD
Anastrozole—Bronchitis—Epirubicin—bone cancer	0.00012	0.00216	CcSEcCtD
Anastrozole—Gastrointestinal disorder—Cisplatin—bone cancer	0.000119	0.00214	CcSEcCtD
Anastrozole—Depression—Methotrexate—bone cancer	0.000119	0.00213	CcSEcCtD
Anastrozole—Pain—Cisplatin—bone cancer	0.000118	0.00212	CcSEcCtD
Anastrozole—Stevens-Johnson syndrome—Methotrexate—bone cancer	0.000118	0.00212	CcSEcCtD
Anastrozole—Alanine aminotransferase increased—Doxorubicin—bone cancer	0.000118	0.00212	CcSEcCtD
Anastrozole—Dysphagia—Doxorubicin—bone cancer	0.000116	0.00207	CcSEcCtD
Anastrozole—Influenza—Doxorubicin—bone cancer	0.000116	0.00207	CcSEcCtD
Anastrozole—Sweating—Methotrexate—bone cancer	0.000114	0.00205	CcSEcCtD
Anastrozole—Feeling abnormal—Cisplatin—bone cancer	0.000114	0.00204	CcSEcCtD
Anastrozole—Weight increased—Epirubicin—bone cancer	0.000114	0.00204	CcSEcCtD
Anastrozole—Weight decreased—Epirubicin—bone cancer	0.000113	0.00203	CcSEcCtD
Anastrozole—Angina pectoris—Doxorubicin—bone cancer	0.000113	0.00202	CcSEcCtD
Anastrozole—Hepatobiliary disease—Methotrexate—bone cancer	0.000113	0.00202	CcSEcCtD
Anastrozole—Bronchitis—Doxorubicin—bone cancer	0.000111	0.00199	CcSEcCtD
Anastrozole—Stevens-Johnson syndrome—Epirubicin—bone cancer	0.00011	0.00198	CcSEcCtD
Anastrozole—CYP19A1—Tryptophan metabolism—CYP3A4—bone cancer	0.00011	0.0215	CbGpPWpGaD
Anastrozole—Body temperature increased—Cisplatin—bone cancer	0.000109	0.00196	CcSEcCtD
Anastrozole—Neuropathy peripheral—Epirubicin—bone cancer	0.000109	0.00196	CcSEcCtD
Anastrozole—Jaundice—Epirubicin—bone cancer	0.000109	0.00195	CcSEcCtD
Anastrozole—Urinary tract infection—Epirubicin—bone cancer	0.000108	0.00194	CcSEcCtD
Anastrozole—Haemoglobin—Methotrexate—bone cancer	0.000107	0.00193	CcSEcCtD
Anastrozole—Haemorrhage—Methotrexate—bone cancer	0.000107	0.00192	CcSEcCtD
Anastrozole—Hepatitis—Methotrexate—bone cancer	0.000107	0.00192	CcSEcCtD
Anastrozole—Sweating—Epirubicin—bone cancer	0.000107	0.00192	CcSEcCtD
Anastrozole—Pharyngitis—Methotrexate—bone cancer	0.000106	0.0019	CcSEcCtD
Anastrozole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000106	0.0207	CbGpPWpGaD
Anastrozole—Hepatobiliary disease—Epirubicin—bone cancer	0.000105	0.00189	CcSEcCtD
Anastrozole—Weight increased—Doxorubicin—bone cancer	0.000105	0.00189	CcSEcCtD
Anastrozole—Weight decreased—Doxorubicin—bone cancer	0.000105	0.00188	CcSEcCtD
Anastrozole—Sinusitis—Epirubicin—bone cancer	0.000104	0.00187	CcSEcCtD
Anastrozole—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.000102	0.00183	CcSEcCtD
Anastrozole—Hypersensitivity—Cisplatin—bone cancer	0.000102	0.00183	CcSEcCtD
Anastrozole—Erythema multiforme—Methotrexate—bone cancer	0.000101	0.00181	CcSEcCtD
Anastrozole—Neuropathy peripheral—Doxorubicin—bone cancer	0.000101	0.00181	CcSEcCtD
Anastrozole—Haemoglobin—Epirubicin—bone cancer	0.0001	0.0018	CcSEcCtD
Anastrozole—Jaundice—Doxorubicin—bone cancer	0.0001	0.0018	CcSEcCtD
Anastrozole—Rhinitis—Epirubicin—bone cancer	0.0001	0.0018	CcSEcCtD
Anastrozole—Urinary tract infection—Doxorubicin—bone cancer	0.0001	0.0018	CcSEcCtD
Anastrozole—Hepatitis—Epirubicin—bone cancer	0.0001	0.00179	CcSEcCtD
Anastrozole—Haemorrhage—Epirubicin—bone cancer	0.0001	0.00179	CcSEcCtD
Anastrozole—Asthenia—Cisplatin—bone cancer	9.92e-05	0.00178	CcSEcCtD
Anastrozole—Pharyngitis—Epirubicin—bone cancer	9.92e-05	0.00178	CcSEcCtD
Anastrozole—Sweating—Doxorubicin—bone cancer	9.88e-05	0.00177	CcSEcCtD
Anastrozole—Oedema peripheral—Epirubicin—bone cancer	9.85e-05	0.00177	CcSEcCtD
Anastrozole—Hepatobiliary disease—Doxorubicin—bone cancer	9.74e-05	0.00175	CcSEcCtD
Anastrozole—Sinusitis—Doxorubicin—bone cancer	9.67e-05	0.00173	CcSEcCtD
Anastrozole—CYP1A2—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	9.66e-05	0.0189	CbGpPWpGaD
Anastrozole—Diarrhoea—Cisplatin—bone cancer	9.46e-05	0.0017	CcSEcCtD
Anastrozole—CYP2C9—Xenobiotics—CYP3A4—bone cancer	9.46e-05	0.0185	CbGpPWpGaD
Anastrozole—Erythema multiforme—Epirubicin—bone cancer	9.45e-05	0.0017	CcSEcCtD
Anastrozole—Alopecia—Methotrexate—bone cancer	9.44e-05	0.00169	CcSEcCtD
Anastrozole—Erythema—Methotrexate—bone cancer	9.3e-05	0.00167	CcSEcCtD
Anastrozole—Haemoglobin—Doxorubicin—bone cancer	9.3e-05	0.00167	CcSEcCtD
Anastrozole—Rhinitis—Doxorubicin—bone cancer	9.27e-05	0.00166	CcSEcCtD
Anastrozole—Haemorrhage—Doxorubicin—bone cancer	9.25e-05	0.00166	CcSEcCtD
Anastrozole—Hepatitis—Doxorubicin—bone cancer	9.25e-05	0.00166	CcSEcCtD
Anastrozole—Pharyngitis—Doxorubicin—bone cancer	9.18e-05	0.00165	CcSEcCtD
Anastrozole—Oedema peripheral—Doxorubicin—bone cancer	9.11e-05	0.00163	CcSEcCtD
Anastrozole—Dysgeusia—Methotrexate—bone cancer	9.1e-05	0.00163	CcSEcCtD
Anastrozole—CYP19A1—Ovarian Infertility Genes—CDK4—bone cancer	9.1e-05	0.0178	CbGpPWpGaD
Anastrozole—CYP2C9—Tamoxifen metabolism—CYP3A4—bone cancer	9.09e-05	0.0178	CbGpPWpGaD
Anastrozole—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	9.05e-05	0.0177	CbGpPWpGaD
Anastrozole—Back pain—Methotrexate—bone cancer	8.99e-05	0.00161	CcSEcCtD
Anastrozole—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	8.87e-05	0.0174	CbGpPWpGaD
Anastrozole—Alopecia—Epirubicin—bone cancer	8.83e-05	0.00159	CcSEcCtD
Anastrozole—Vomiting—Cisplatin—bone cancer	8.79e-05	0.00158	CcSEcCtD
Anastrozole—CYP1A2—Estrogen metabolism—CYP3A4—bone cancer	8.79e-05	0.0172	CbGpPWpGaD
Anastrozole—CYP19A1—Oxidation by Cytochrome P450—CYP3A4—bone cancer	8.76e-05	0.0171	CbGpPWpGaD
Anastrozole—Erythema multiforme—Doxorubicin—bone cancer	8.74e-05	0.00157	CcSEcCtD
Anastrozole—Rash—Cisplatin—bone cancer	8.72e-05	0.00156	CcSEcCtD
Anastrozole—Dermatitis—Cisplatin—bone cancer	8.71e-05	0.00156	CcSEcCtD
Anastrozole—Erythema—Epirubicin—bone cancer	8.7e-05	0.00156	CcSEcCtD
Anastrozole—Ill-defined disorder—Methotrexate—bone cancer	8.63e-05	0.00155	CcSEcCtD
Anastrozole—Anaemia—Methotrexate—bone cancer	8.59e-05	0.00154	CcSEcCtD
Anastrozole—Tension—Epirubicin—bone cancer	8.54e-05	0.00153	CcSEcCtD
Anastrozole—Dysgeusia—Epirubicin—bone cancer	8.52e-05	0.00153	CcSEcCtD
Anastrozole—Nervousness—Epirubicin—bone cancer	8.45e-05	0.00152	CcSEcCtD
Anastrozole—CYP2C9—Metapathway biotransformation—CYP4V2—bone cancer	8.43e-05	0.0165	CbGpPWpGaD
Anastrozole—CYP1A2—Aflatoxin activation and detoxification—CYP3A4—bone cancer	8.42e-05	0.0165	CbGpPWpGaD
Anastrozole—Back pain—Epirubicin—bone cancer	8.42e-05	0.00151	CcSEcCtD
Anastrozole—Malaise—Methotrexate—bone cancer	8.38e-05	0.0015	CcSEcCtD
Anastrozole—Leukopenia—Methotrexate—bone cancer	8.32e-05	0.00149	CcSEcCtD
Anastrozole—Nausea—Cisplatin—bone cancer	8.21e-05	0.00147	CcSEcCtD
Anastrozole—Alopecia—Doxorubicin—bone cancer	8.17e-05	0.00147	CcSEcCtD
Anastrozole—Cough—Methotrexate—bone cancer	8.11e-05	0.00146	CcSEcCtD
Anastrozole—CYP1A2—Xenobiotics—CYP3A4—bone cancer	8.08e-05	0.0158	CbGpPWpGaD
Anastrozole—Ill-defined disorder—Epirubicin—bone cancer	8.07e-05	0.00145	CcSEcCtD
Anastrozole—Erythema—Doxorubicin—bone cancer	8.05e-05	0.00144	CcSEcCtD
Anastrozole—Anaemia—Epirubicin—bone cancer	8.04e-05	0.00144	CcSEcCtD
Anastrozole—Arthralgia—Methotrexate—bone cancer	7.92e-05	0.00142	CcSEcCtD
Anastrozole—Myalgia—Methotrexate—bone cancer	7.92e-05	0.00142	CcSEcCtD
Anastrozole—Chest pain—Methotrexate—bone cancer	7.92e-05	0.00142	CcSEcCtD
Anastrozole—Tension—Doxorubicin—bone cancer	7.9e-05	0.00142	CcSEcCtD
Anastrozole—Dysgeusia—Doxorubicin—bone cancer	7.88e-05	0.00141	CcSEcCtD
Anastrozole—Malaise—Epirubicin—bone cancer	7.85e-05	0.00141	CcSEcCtD
Anastrozole—Discomfort—Methotrexate—bone cancer	7.82e-05	0.0014	CcSEcCtD
Anastrozole—Nervousness—Doxorubicin—bone cancer	7.82e-05	0.0014	CcSEcCtD
Anastrozole—Leukopenia—Epirubicin—bone cancer	7.79e-05	0.0014	CcSEcCtD
Anastrozole—Back pain—Doxorubicin—bone cancer	7.79e-05	0.0014	CcSEcCtD
Anastrozole—CYP1A2—Tamoxifen metabolism—CYP3A4—bone cancer	7.77e-05	0.0152	CbGpPWpGaD
Anastrozole—Confusional state—Methotrexate—bone cancer	7.65e-05	0.00137	CcSEcCtD
Anastrozole—Cough—Epirubicin—bone cancer	7.59e-05	0.00136	CcSEcCtD
Anastrozole—Anaphylactic shock—Methotrexate—bone cancer	7.59e-05	0.00136	CcSEcCtD
Anastrozole—Infection—Methotrexate—bone cancer	7.54e-05	0.00135	CcSEcCtD
Anastrozole—Hypertension—Epirubicin—bone cancer	7.51e-05	0.00135	CcSEcCtD
Anastrozole—Ill-defined disorder—Doxorubicin—bone cancer	7.47e-05	0.00134	CcSEcCtD
Anastrozole—Anaemia—Doxorubicin—bone cancer	7.44e-05	0.00134	CcSEcCtD
Anastrozole—Myalgia—Epirubicin—bone cancer	7.41e-05	0.00133	CcSEcCtD
Anastrozole—Arthralgia—Epirubicin—bone cancer	7.41e-05	0.00133	CcSEcCtD
Anastrozole—Chest pain—Epirubicin—bone cancer	7.41e-05	0.00133	CcSEcCtD
Anastrozole—Anxiety—Epirubicin—bone cancer	7.38e-05	0.00132	CcSEcCtD
Anastrozole—Hyperhidrosis—Methotrexate—bone cancer	7.34e-05	0.00132	CcSEcCtD
Anastrozole—Discomfort—Epirubicin—bone cancer	7.32e-05	0.00131	CcSEcCtD
Anastrozole—Malaise—Doxorubicin—bone cancer	7.26e-05	0.0013	CcSEcCtD
Anastrozole—Dry mouth—Epirubicin—bone cancer	7.24e-05	0.0013	CcSEcCtD
Anastrozole—Anorexia—Methotrexate—bone cancer	7.23e-05	0.0013	CcSEcCtD
Anastrozole—Leukopenia—Doxorubicin—bone cancer	7.21e-05	0.00129	CcSEcCtD
Anastrozole—CYP1A2—Metapathway biotransformation—CYP4V2—bone cancer	7.21e-05	0.0141	CbGpPWpGaD
Anastrozole—CYP19A1—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	7.19e-05	0.0141	CbGpPWpGaD
Anastrozole—Confusional state—Epirubicin—bone cancer	7.16e-05	0.00128	CcSEcCtD
Anastrozole—Oedema—Epirubicin—bone cancer	7.1e-05	0.00127	CcSEcCtD
Anastrozole—Anaphylactic shock—Epirubicin—bone cancer	7.1e-05	0.00127	CcSEcCtD
Anastrozole—Infection—Epirubicin—bone cancer	7.05e-05	0.00127	CcSEcCtD
Anastrozole—Cough—Doxorubicin—bone cancer	7.03e-05	0.00126	CcSEcCtD
Anastrozole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	6.98e-05	0.0137	CbGpPWpGaD
Anastrozole—Hypertension—Doxorubicin—bone cancer	6.95e-05	0.00125	CcSEcCtD
Anastrozole—Musculoskeletal discomfort—Methotrexate—bone cancer	6.91e-05	0.00124	CcSEcCtD
Anastrozole—Hyperhidrosis—Epirubicin—bone cancer	6.86e-05	0.00123	CcSEcCtD
Anastrozole—Insomnia—Methotrexate—bone cancer	6.86e-05	0.00123	CcSEcCtD
Anastrozole—Chest pain—Doxorubicin—bone cancer	6.85e-05	0.00123	CcSEcCtD
Anastrozole—Arthralgia—Doxorubicin—bone cancer	6.85e-05	0.00123	CcSEcCtD
Anastrozole—Myalgia—Doxorubicin—bone cancer	6.85e-05	0.00123	CcSEcCtD
Anastrozole—Anxiety—Doxorubicin—bone cancer	6.83e-05	0.00123	CcSEcCtD
Anastrozole—Paraesthesia—Methotrexate—bone cancer	6.81e-05	0.00122	CcSEcCtD
Anastrozole—Discomfort—Doxorubicin—bone cancer	6.77e-05	0.00122	CcSEcCtD
Anastrozole—Anorexia—Epirubicin—bone cancer	6.77e-05	0.00121	CcSEcCtD
Anastrozole—Dyspnoea—Methotrexate—bone cancer	6.77e-05	0.00121	CcSEcCtD
Anastrozole—Somnolence—Methotrexate—bone cancer	6.75e-05	0.00121	CcSEcCtD
Anastrozole—Dry mouth—Doxorubicin—bone cancer	6.7e-05	0.0012	CcSEcCtD
Anastrozole—Dyspepsia—Methotrexate—bone cancer	6.68e-05	0.0012	CcSEcCtD
Anastrozole—Confusional state—Doxorubicin—bone cancer	6.63e-05	0.00119	CcSEcCtD
Anastrozole—Decreased appetite—Methotrexate—bone cancer	6.6e-05	0.00118	CcSEcCtD
Anastrozole—Oedema—Doxorubicin—bone cancer	6.57e-05	0.00118	CcSEcCtD
Anastrozole—Anaphylactic shock—Doxorubicin—bone cancer	6.57e-05	0.00118	CcSEcCtD
Anastrozole—Gastrointestinal disorder—Methotrexate—bone cancer	6.55e-05	0.00118	CcSEcCtD
Anastrozole—Fatigue—Methotrexate—bone cancer	6.54e-05	0.00117	CcSEcCtD
Anastrozole—Infection—Doxorubicin—bone cancer	6.53e-05	0.00117	CcSEcCtD
Anastrozole—CYP2C9—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	6.49e-05	0.0127	CbGpPWpGaD
Anastrozole—Pain—Methotrexate—bone cancer	6.49e-05	0.00116	CcSEcCtD
Anastrozole—Musculoskeletal discomfort—Epirubicin—bone cancer	6.47e-05	0.00116	CcSEcCtD
Anastrozole—Insomnia—Epirubicin—bone cancer	6.42e-05	0.00115	CcSEcCtD
Anastrozole—Paraesthesia—Epirubicin—bone cancer	6.38e-05	0.00114	CcSEcCtD
Anastrozole—Hyperhidrosis—Doxorubicin—bone cancer	6.35e-05	0.00114	CcSEcCtD
Anastrozole—Dyspnoea—Epirubicin—bone cancer	6.33e-05	0.00114	CcSEcCtD
Anastrozole—Somnolence—Epirubicin—bone cancer	6.31e-05	0.00113	CcSEcCtD
Anastrozole—Anorexia—Doxorubicin—bone cancer	6.26e-05	0.00112	CcSEcCtD
Anastrozole—Feeling abnormal—Methotrexate—bone cancer	6.25e-05	0.00112	CcSEcCtD
Anastrozole—Dyspepsia—Epirubicin—bone cancer	6.25e-05	0.00112	CcSEcCtD
Anastrozole—Gastrointestinal pain—Methotrexate—bone cancer	6.21e-05	0.00111	CcSEcCtD
Anastrozole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	6.19e-05	0.0121	CbGpPWpGaD
Anastrozole—Decreased appetite—Epirubicin—bone cancer	6.17e-05	0.00111	CcSEcCtD
Anastrozole—Gastrointestinal disorder—Epirubicin—bone cancer	6.13e-05	0.0011	CcSEcCtD
Anastrozole—Fatigue—Epirubicin—bone cancer	6.12e-05	0.0011	CcSEcCtD
Anastrozole—Pain—Epirubicin—bone cancer	6.07e-05	0.00109	CcSEcCtD
Anastrozole—Constipation—Epirubicin—bone cancer	6.07e-05	0.00109	CcSEcCtD
Anastrozole—Urticaria—Methotrexate—bone cancer	6.03e-05	0.00108	CcSEcCtD
Anastrozole—Abdominal pain—Methotrexate—bone cancer	6e-05	0.00108	CcSEcCtD
Anastrozole—Body temperature increased—Methotrexate—bone cancer	6e-05	0.00108	CcSEcCtD
Anastrozole—Musculoskeletal discomfort—Doxorubicin—bone cancer	5.99e-05	0.00107	CcSEcCtD
Anastrozole—Insomnia—Doxorubicin—bone cancer	5.94e-05	0.00107	CcSEcCtD
Anastrozole—Paraesthesia—Doxorubicin—bone cancer	5.9e-05	0.00106	CcSEcCtD
Anastrozole—Dyspnoea—Doxorubicin—bone cancer	5.86e-05	0.00105	CcSEcCtD
Anastrozole—Feeling abnormal—Epirubicin—bone cancer	5.85e-05	0.00105	CcSEcCtD
Anastrozole—Somnolence—Doxorubicin—bone cancer	5.84e-05	0.00105	CcSEcCtD
Anastrozole—Gastrointestinal pain—Epirubicin—bone cancer	5.81e-05	0.00104	CcSEcCtD
Anastrozole—Dyspepsia—Doxorubicin—bone cancer	5.78e-05	0.00104	CcSEcCtD
Anastrozole—Decreased appetite—Doxorubicin—bone cancer	5.71e-05	0.00102	CcSEcCtD
Anastrozole—Gastrointestinal disorder—Doxorubicin—bone cancer	5.67e-05	0.00102	CcSEcCtD
Anastrozole—Fatigue—Doxorubicin—bone cancer	5.66e-05	0.00102	CcSEcCtD
Anastrozole—Urticaria—Epirubicin—bone cancer	5.64e-05	0.00101	CcSEcCtD
Anastrozole—Constipation—Doxorubicin—bone cancer	5.62e-05	0.00101	CcSEcCtD
Anastrozole—Pain—Doxorubicin—bone cancer	5.62e-05	0.00101	CcSEcCtD
Anastrozole—Abdominal pain—Epirubicin—bone cancer	5.61e-05	0.00101	CcSEcCtD
Anastrozole—Body temperature increased—Epirubicin—bone cancer	5.61e-05	0.00101	CcSEcCtD
Anastrozole—Hypersensitivity—Methotrexate—bone cancer	5.59e-05	0.001	CcSEcCtD
Anastrozole—CYP3A4—Metapathway biotransformation—CYP4V2—bone cancer	5.56e-05	0.0109	CbGpPWpGaD
Anastrozole—Asthenia—Methotrexate—bone cancer	5.44e-05	0.000977	CcSEcCtD
Anastrozole—Feeling abnormal—Doxorubicin—bone cancer	5.41e-05	0.000972	CcSEcCtD
Anastrozole—Gastrointestinal pain—Doxorubicin—bone cancer	5.37e-05	0.000964	CcSEcCtD
Anastrozole—Pruritus—Methotrexate—bone cancer	5.37e-05	0.000963	CcSEcCtD
Anastrozole—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	5.29e-05	0.0103	CbGpPWpGaD
Anastrozole—Hypersensitivity—Epirubicin—bone cancer	5.23e-05	0.000939	CcSEcCtD
Anastrozole—Urticaria—Doxorubicin—bone cancer	5.22e-05	0.000937	CcSEcCtD
Anastrozole—Abdominal pain—Doxorubicin—bone cancer	5.19e-05	0.000932	CcSEcCtD
Anastrozole—Body temperature increased—Doxorubicin—bone cancer	5.19e-05	0.000932	CcSEcCtD
Anastrozole—Diarrhoea—Methotrexate—bone cancer	5.19e-05	0.000932	CcSEcCtD
Anastrozole—Asthenia—Epirubicin—bone cancer	5.09e-05	0.000914	CcSEcCtD
Anastrozole—CYP19A1—Tryptophan metabolism—MDM2—bone cancer	5.04e-05	0.00987	CbGpPWpGaD
Anastrozole—Pruritus—Epirubicin—bone cancer	5.02e-05	0.000902	CcSEcCtD
Anastrozole—Dizziness—Methotrexate—bone cancer	5.02e-05	0.0009	CcSEcCtD
Anastrozole—Diarrhoea—Epirubicin—bone cancer	4.86e-05	0.000872	CcSEcCtD
Anastrozole—Hypersensitivity—Doxorubicin—bone cancer	4.84e-05	0.000869	CcSEcCtD
Anastrozole—Vomiting—Methotrexate—bone cancer	4.82e-05	0.000866	CcSEcCtD
Anastrozole—Rash—Methotrexate—bone cancer	4.78e-05	0.000859	CcSEcCtD
Anastrozole—Dermatitis—Methotrexate—bone cancer	4.78e-05	0.000858	CcSEcCtD
Anastrozole—Headache—Methotrexate—bone cancer	4.75e-05	0.000853	CcSEcCtD
Anastrozole—Asthenia—Doxorubicin—bone cancer	4.71e-05	0.000846	CcSEcCtD
Anastrozole—Dizziness—Epirubicin—bone cancer	4.7e-05	0.000843	CcSEcCtD
Anastrozole—Pruritus—Doxorubicin—bone cancer	4.65e-05	0.000834	CcSEcCtD
Anastrozole—CYP1A2—Estrogen Receptor Pathway—JUN—bone cancer	4.56e-05	0.00891	CbGpPWpGaD
Anastrozole—Vomiting—Epirubicin—bone cancer	4.52e-05	0.00081	CcSEcCtD
Anastrozole—Nausea—Methotrexate—bone cancer	4.51e-05	0.000809	CcSEcCtD
Anastrozole—Diarrhoea—Doxorubicin—bone cancer	4.5e-05	0.000807	CcSEcCtD
Anastrozole—Rash—Epirubicin—bone cancer	4.48e-05	0.000803	CcSEcCtD
Anastrozole—Dermatitis—Epirubicin—bone cancer	4.47e-05	0.000803	CcSEcCtD
Anastrozole—Headache—Epirubicin—bone cancer	4.45e-05	0.000798	CcSEcCtD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—ATF1—bone cancer	4.35e-05	0.0085	CbGpPWpGaD
Anastrozole—Dizziness—Doxorubicin—bone cancer	4.34e-05	0.00078	CcSEcCtD
Anastrozole—Nausea—Epirubicin—bone cancer	4.22e-05	0.000757	CcSEcCtD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—CHEK2—bone cancer	4.18e-05	0.00818	CbGpPWpGaD
Anastrozole—Vomiting—Doxorubicin—bone cancer	4.18e-05	0.00075	CcSEcCtD
Anastrozole—CYP1A2—Tryptophan metabolism—CYP3A4—bone cancer	4.15e-05	0.00812	CbGpPWpGaD
Anastrozole—Rash—Doxorubicin—bone cancer	4.14e-05	0.000743	CcSEcCtD
Anastrozole—Dermatitis—Doxorubicin—bone cancer	4.14e-05	0.000743	CcSEcCtD
Anastrozole—Headache—Doxorubicin—bone cancer	4.12e-05	0.000739	CcSEcCtD
Anastrozole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	3.93e-05	0.00768	CbGpPWpGaD
Anastrozole—Nausea—Doxorubicin—bone cancer	3.9e-05	0.0007	CcSEcCtD
Anastrozole—CYP2C9—Oxidation by Cytochrome P450—CYP3A4—bone cancer	3.88e-05	0.00758	CbGpPWpGaD
Anastrozole—CYP19A1—Biological oxidations—CYP3A4—bone cancer	3.82e-05	0.00747	CbGpPWpGaD
Anastrozole—CYP19A1—Metapathway biotransformation—CYP3A4—bone cancer	3.77e-05	0.00737	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—TGFBR2—bone cancer	3.63e-05	0.00709	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—BRCA2—bone cancer	3.55e-05	0.00693	CbGpPWpGaD
Anastrozole—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	3.36e-05	0.00656	CbGpPWpGaD
Anastrozole—CYP1A2—Oxidation by Cytochrome P450—CYP3A4—bone cancer	3.31e-05	0.00648	CbGpPWpGaD
Anastrozole—CYP19A1—Biological oxidations—GSTP1—bone cancer	3.27e-05	0.00639	CbGpPWpGaD
Anastrozole—CYP19A1—Metapathway biotransformation—GSTP1—bone cancer	3.22e-05	0.0063	CbGpPWpGaD
Anastrozole—CYP2C9—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	3.18e-05	0.00623	CbGpPWpGaD
Anastrozole—CYP1A2—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	2.72e-05	0.00532	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—CDK4—bone cancer	2.63e-05	0.00514	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—BRAF—bone cancer	2.33e-05	0.00455	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—NDUFA12—bone cancer	2.29e-05	0.00448	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—RB1—bone cancer	2.29e-05	0.00447	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor—RB1—bone cancer	2.24e-05	0.00438	CbGpPWpGaD
Anastrozole—CYP1A2—Phase II conjugation—GSTP1—bone cancer	2.11e-05	0.00413	CbGpPWpGaD
Anastrozole—CYP2C9—Arachidonic acid metabolism—PTGS2—bone cancer	2.01e-05	0.00394	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—MDM2—bone cancer	1.95e-05	0.00381	CbGpPWpGaD
Anastrozole—CYP1A2—Tryptophan metabolism—MDM2—bone cancer	1.91e-05	0.00373	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—NT5C3A—bone cancer	1.9e-05	0.00371	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—bone cancer	1.84e-05	0.0036	CbGpPWpGaD
Anastrozole—CYP1A2—Arachidonic acid metabolism—PTGS2—bone cancer	1.72e-05	0.00336	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—JUN—bone cancer	1.69e-05	0.00331	CbGpPWpGaD
Anastrozole—CYP2C9—Biological oxidations—CYP3A4—bone cancer	1.69e-05	0.00331	CbGpPWpGaD
Anastrozole—CYP2C9—Metapathway biotransformation—CYP3A4—bone cancer	1.67e-05	0.00326	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	1.66e-05	0.00324	CbGpPWpGaD
Anastrozole—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	1.47e-05	0.00288	CbGpPWpGaD
Anastrozole—CYP2C9—Biological oxidations—GSTP1—bone cancer	1.45e-05	0.00283	CbGpPWpGaD
Anastrozole—CYP1A2—Biological oxidations—CYP3A4—bone cancer	1.44e-05	0.00283	CbGpPWpGaD
Anastrozole—CYP2C9—Metapathway biotransformation—GSTP1—bone cancer	1.43e-05	0.00279	CbGpPWpGaD
Anastrozole—CYP1A2—Metapathway biotransformation—CYP3A4—bone cancer	1.43e-05	0.00279	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—EGFR—bone cancer	1.33e-05	0.0026	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	1.3e-05	0.00255	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—bone cancer	1.3e-05	0.00255	CbGpPWpGaD
Anastrozole—CYP1A2—Biological oxidations—GSTP1—bone cancer	1.24e-05	0.00242	CbGpPWpGaD
Anastrozole—CYP1A2—Metapathway biotransformation—GSTP1—bone cancer	1.22e-05	0.00238	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—TP53—bone cancer	1.12e-05	0.00219	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—NDUFA12—bone cancer	1.01e-05	0.00198	CbGpPWpGaD
Anastrozole—CYP3A4—Biological oxidations—GSTP1—bone cancer	9.54e-06	0.00187	CbGpPWpGaD
Anastrozole—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	9.41e-06	0.00184	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—NDUFA12—bone cancer	8.66e-06	0.00169	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—NT5C3A—bone cancer	8.4e-06	0.00164	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—ENO2—bone cancer	8.31e-06	0.00163	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—DHFR—bone cancer	7.71e-06	0.00151	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—GNA11—bone cancer	7.21e-06	0.00141	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—NT5C3A—bone cancer	7.18e-06	0.0014	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—NDUFA12—bone cancer	6.68e-06	0.00131	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—CYP3A4—bone cancer	6.53e-06	0.00128	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	6.5e-06	0.00127	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—GSTP1—bone cancer	5.59e-06	0.00109	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—NT5C3A—bone cancer	5.54e-06	0.00108	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—ENO2—bone cancer	3.68e-06	0.000719	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—DHFR—bone cancer	3.41e-06	0.000667	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—GNA11—bone cancer	3.19e-06	0.000624	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—ENO2—bone cancer	3.14e-06	0.000615	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—DHFR—bone cancer	2.92e-06	0.00057	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—PTGS2—bone cancer	2.9e-06	0.000566	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—CYP3A4—bone cancer	2.89e-06	0.000566	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.88e-06	0.000563	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—GNA11—bone cancer	2.73e-06	0.000533	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—GSTP1—bone cancer	2.47e-06	0.000484	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—CYP3A4—bone cancer	2.47e-06	0.000483	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.46e-06	0.000481	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—ENO2—bone cancer	2.43e-06	0.000474	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—DHFR—bone cancer	2.25e-06	0.00044	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—GSTP1—bone cancer	2.11e-06	0.000413	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—GNA11—bone cancer	2.1e-06	0.000411	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—GSTP1—bone cancer	1.63e-06	0.000319	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—PTGS2—bone cancer	1.28e-06	0.000251	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—PTGS2—bone cancer	1.09e-06	0.000214	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—PTGS2—bone cancer	8.45e-07	0.000165	CbGpPWpGaD
